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Discovering the function of an unknown protein, particu-
larly one with neither structural nor functional correlates,
is a daunting task. Interaction analyses determine binding
partners, whereas DNA transfection, either transient or
stable, leads to intracellular expression, though not nec-
essarily at physiologically relevant levels. In theory, direct
intracellular protein delivery (protein transduction) pro-
vides a conceptually simpler alternative, but in practice
the approach is problematic. Domains such as HIV TAT
protein are valuable, but their effectiveness is protein
specific. Similarly, the delivery of intact proteins via en-
docytic pathways (e.g. using liposomes) is problematic for
functional analysis because of the potential for protein
degradation in the endosomes/lysosomes. Consequently,
recent reports that microspheres can deliver bio-cargoes
into cells via a non-endocytic, energy-independent path-
way offer an exciting and promising alternative for in vitro
delivery of functional protein. In order for such promise to
be fully exploited, microspheres are required that (i) are
stably linked to proteins, (ii) can deliver those proteins
with good efficiency, (iii) release functional protein once
inside the cells, and (iv) permit concomitant tracking.
Herein, we report the application of microspheres to suc-
cessfully address all of these criteria simultaneously, for
the first time. After cellular uptake, protein release was
autocatalyzed by the reducing cytoplasmic environment.
Outside of cells, the covalent microsphere–protein link-
age was stable for >90 h at 37 °C. Using conservative
methods of estimation, 74.3% 5.6% of cells were shown
to take up these microspheres after 24 h of incubation,
with the whole process of delivery and intracellular pro-
tein release occurring within 36 h. Intended for in vitro
functional protein research, this approach will enable
study of the consequences of protein delivery at physi-
ologically relevant levels, without recourse to nucleic
acids, and offers a useful alternative to commercial pro-
tein transfection reagents such as Chariot™. We also
provide clear immunostaining evidence to resolve resid-
ual controversy surrounding FACS-based assessment
of microsphere uptake. Molecular & Cellular Proteom-
ics 13: 10.1074/mcp.O113.034900, 1543–1551, 2014.
Many proteomic techniques can be used to build a picture
of a protein with unknown function, but eventually the indi-
vidual protein’s activity must be studied. Traditional transfec-
tion of encoding DNA permits intracellular expression, but
often at uncontrolled, nonphysiological levels. Moreover, DNA
transfection can neither deliver protein–inhibitor complexes
nor readily deliver multiple proteins in a single experiment and
thus exploit knowledge from proteomic protein–protein inter-
action analyses. In contrast, a truly generic protein transduc-
tion reagent could theoretically address all possibilities. We
believe that polymeric microspheres could fulfill this role, and
we have recently synthesized and characterized dual-func-
tionalized, bio-compatible microspheres that permit intracel-
lular tracking (1). Herein, we now report the development of
those microspheres into a protein transduction reagent that
can carry protein stably, deliver it efficiently to cells, release
the protein in the cytoplasm, and concurrently permit fluores-
cent imaging of transduced cells.
Phagocytosis of microspheres was first observed over 30
years ago (2). Perhaps more unexpectedly, uptake of polysty-
rene microspheres has recently been reported in many other,
nonphagocytic cell types, some of which are traditionally
considered to be resistant to DNA transfection and/or protein
transduction. For example, microspheres are taken up readily
by primary immune cells (3), embryonic stem cells (4), human
neural stem cells (5), differentiating mouse neural stem cells
(5), and several nonphagocytic cell lines (3, 6, 7). In all in-
stances, the reported efficiency of cellular uptake is high, with
“beadfection” of up to 90% of cells being typical (4, 5, 8). No
additional reagents aside from the microspheres themselves
are required in order to promote cellular uptake, and critically,
no toxicity has been observed in any of the cell types bead-
fected, including HEK293T and L929 cells 2 days after
beadfection (8), E14g2a embryonic stem cells 3 days after
beadfection (4), and mouse and human neural stem cells 30
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days after beadfection (5). In the latter case, the microspheres
did not have any deleterious effect on the differentiation of
human neural stem cells 30 days after beadfection (5).
The mechanism of microsphere entry is also nontoxic, and
compelling evidence has been published recently that poly-
styrene-based microspheres (from 0.2 m to as large as 2
m) enter cells via a non-endocytosis, energy-independent
mechanism (8). Although unusual, such a mechanism is con-
sistent with claims for the commercial reagent Chariot™ (9).
Interestingly, a non-endocytic, energy-independent mecha-
nism has also been reported for the entry of rhenium cluster/
polymer hybrid particles into HeLa cells (10). Failure of the
microspheres to be endocytosed, at least via a clathrin-de-
pendent mechanism, is perhaps to be predicted, as their
diameter considerably exceeds that of clathrin-coated vesi-
cles (typically 100 nm). Bradley and co-workers (8) propose
that the entry mechanism for polystyrene-based micro-
spheres is one of passive diffusion in which the microsphere
interacts with the membrane, anchors, and, after membrane
reorganization, enters the cell, resulting in direct cytoplasmic
localization.
For functional analysis following transduction, the avoid-
ance of endocytosis or phagocytosis is particularly relevant,
as endocytosed particles are destined for endosomes and
then, normally, for the lysosomes. The lowered pH of the
endosome and, more seriously, the acidic and hydrolytic en-
vironment of the lysosome risk disruption of the protein struc-
ture and/or function. In contrast, for vaccine delivery (where
liposomes can be employed), such exposure is advantageous
because protein breakdown forms an essential part of antigen
presentation. The potential for protein breakdown in endo-
somes is also irrelevant for the delivery of protein/peptide
drugs such as insulin (for which microencapsulation has
proven effective for long-term controlled drug release (11,
12)), as these drugs typically function in the extracellular en-
vironment, often exerting their effects by binding to mem-
brane-bound receptors. Thus, although vehicles such as lipo-
somes and nanoparticles are employed both extensively and
successfully as drug and vaccine delivery vectors in vivo
(13–16), they are far from ideal for studying the biological
effect of a delivered protein in vitro. Colloidal particles are also
endocytosed (17), and therefore these delivery vehicles may
present similar disadvantages.
Traditionally, protein transduction domains such as HIV
TAT (18–20) or other cell-penetrating peptides (21–23) are
used to deliver proteins to cells. Whereas positively charged
peptides such as TAT are thought to enter the cells via mac-
ropinocytosis (reviewed in Ref. 24), a recent publication sug-
gests that at least some cell-penetrating peptide/bio-cargo
complexes (siRNA) are endocytosed (25). Here, although the
cargoes avoid the lysosomes, acidification of the endosome is
required for endosomal escape of the delivered cargo, and
indeed, acidification appears to be a recurring requirement for
endosomal escape of biomolecular cargoes using cell-pene-
trating peptides (reviewed in Ref. 24). Consequently, cell-
penetrating peptides are unlikely to become generic tools for
functional protein delivery.
In contrast, the recent demonstrations that polystyrene mi-
crospheres can carry a variety of molecular cargoes with them
into the cytoplasm (4, 5, 7, 26, 27) make them particularly
exciting as potential vectors for delivering functional proteins
and/or protein complexes. -Galactosidase retains its activity
when delivered via this route (7), confirming the potential of
microspheres to act as generic protein-delivery vehicles.
However, delivered proteins have to date remained tethered
to the microspheres, and thus existing studies are limited to
proteins that are active in the cytoplasm and, critically, retain
their activity when immobilized on polystyrene. For the broad-
based study of protein function, the subsequent release of the
delivered protein within the cell is desirable.
An ideal technology would deliver any protein to any cell
type and release that protein in the cell, where it could under-
take its normal activity. Here we report the first example of
such a microsphere-based approach. Protein is delivered on
microspheres and then released in the cell by the reducing
cytoplasmic environment. This release is mediated by a linker
that attaches the protein stably and covalently to the micro-
spheres in vitro but intracellularly is cleaved over a period of
hours. It has already been shown that microspheres are taken
up with high efficiency by a range of cell types and can carry
a variety of cargoes. Because the chemistry of the linker
described herein is amenable to linkage with any molecule
containing a free amine moiety, the technology provides a
new generic platform for in vitro, cell-based delivery of indi-
vidual proteins, protein complexes, protein mixtures, or other
amino-functionalized molecules.
EXPERIMENTAL PROCEDURES
All chemical reagents were purchased from Sigma-Aldrich (UK)
unless otherwise stated.
Derivatization of Microspheres with a Cell-cleavable Linker—Car-
boxyl shelled microspheres 1 (Scheme 1, 30 mg) were synthesized as
described previously (1) and then isolated via centrifugation (2 min,
12,000g), resuspended in 1 ml of DMF1 via ultrasonication (2 min), and
added to a reaction mix containing 3-(2-pyridyldithio)propionyl hydra-
zide 2 (Pierce, Loughborough, UK) (9.2 mg, 40.1 mol) and O-(ben-
zotriazol-1-yl)-N,N,N,N-tetramethyluronium tetrafluoro-borate (TBTU)
(12.9 mg, 40.1 mol) in 1 ml of DMF, to which N,N-diisopropylethyl-
amine (7.2 l, 40.1 mol) was then added. After washing (twice with
1 ml of DMF each time) the microspheres were resuspended in the
reaction mixture and incubated for 1 h at room temperature with
shaking. Microspheres were then washed with DMF (three times
with 1 ml each time) and collected via centrifugation. The resulting
pellet of thiol-reactive microspheres 3 was resuspended in 1 ml of
DMF, and 3-mercaptopropionic acid (3.5 l, 40.1 mol) was added.
1 The abbreviations used are: DMF, N,N-dimethylformamide; EDAC/
EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; GFP, green
fluorescent protein; MES, 2-(N-morpholino)ethanesulfonic acid;
PBS, phosphate-buffered saline; TBTU, O-(benzotriazol-1-yl)-N,N,N,N-
tetramethyluronium tetrafluoro-borate.
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The reaction was incubated at room temperature for 1 h with
shaking. Microspheres 4 were isolated via centrifugation and sub-
sequently washed with DMF (five times with 1 ml each time) using
centrifugation and ultrasonication.
Coupling of DY-590 Maleimide-derivatized Dyes to Microspheres—
Microspheres 4 (Scheme 1, 5.0 mg) were washed with DMF (twice
with 1 ml each time), with centrifugation (5 min, 6000 rpm) and
decantation of the supernatant after each wash, and then resus-
pended in DMF (1 ml). A solution of fluorescent dye (DY-590 maleim-
ide, Dyomics, Jena, Germany) in DMF (10 l, 1.32 mM) was added to
the suspension of microspheres, which was then shaken at room
temperature for 2 h. The resultant internally labeled microspheres 5
were isolated via centrifugation (2 min, 6000 rpm) and decantation of
the supernatant, purified with several wash/centrifugation cycles
(DMF (five washes with 1 ml each) and water (two washes with 1 ml
each)), and finally resuspended in water (1 ml).
Conjugation of GFP to Microspheres—GFPuv bearing an N-termi-
nal His6 tag was expressed in Escherichia coli Tuner DE3™ cells
(Novagen, Nottingham, UK) and purified using nickel-nitrilotriacetic
acid agarose (Novagen) before dialysis into 2-(N-morpholino)ethane-
sulfonic acid (MES) buffer (50 mM, pH 6.0). Fluorescent microspheres
5 (1 mg) were pelleted via centrifugation (2 min, 12,000g) and resus-
pended in 100 l of MES buffer (50 mM, pH 6.0). 200 l of MES buffer
(50 mM, pH 6.0) containing GFPuv (500 g, 18.5 nmol) was added to
the microspheres, and the reaction mixture incubated at room tem-
perature with rolling for 15 min. EDAC (0.2 mg, 1.1  103 mmol)
dissolved in 100 l of MES (50 mM, pH 6.0) was added to the reaction
and the pH was adjusted to 6.5 by the addition of aqueous NaOH (0.5
M). After incubation for 2 h at room temperature with rolling, micro-
spheres were recovered via centrifugation and washed with sodium
phosphate buffer (100 mM, pH 7.2; five washes with 500 l each) prior
to resuspension in sodium phosphate buffer (100 mM, pH 7.2) at a
concentration of 5 mg/ml.
Beadfection—HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% v/v fetal bovine
serum (FBS), 100 IU/ml penicillin, 100 g/ml streptomycin, 1 mM
sodium pyruvate, 1 nonessential amino acid supplement, and 4 mM
L-glutamine. Cells were seeded as required and incubated for 24 h at
37 °C with 5% CO2. The medium was then replaced with fresh
medium containing conjugated microspheres (50 g/ml) as indicated,
and the cells were incubated as required.
Epifluorescent Microscopy Imaging of Beadfected Cells—HeLa
cells were seeded (6  104 cells/well) in four-well chamber slides
(Nunc, Loughborough, UK), beadfected, and incubated as specified.
Cells were imaged directly in medium using a Zeiss Axiovert 200 M
fluorescence microscope (63 objective) fitted with a Hamamatsu
Orca charge-coupled device camera driven by Volocity 4.2.1 software
(Improvision, Coventry, UK) and equipped with an ASI Z stage (Zeiss,
Cambridge, UK). GFP fluorescence was detected using Zeiss filter set
10 (excitation 450–490 nm, emission 515–565 nm), and DY-590
fluorescence was detected using Zeiss filter set 15 (excitation 546/12
nm, emission LP 590 nm). For z-stack series, images were taken in
0.7-m z-steps by using the motorized Z stage, from the bottom to
the top focal plane of the cells (10 to 12 slices).
Beadfection with Subsequent Fixation/Permeabilization and Con-
focal Microscopy Imaging—HeLa cells were seeded (5  103 cells/
well) into six-well cell culture dishes containing sterile coverslips,
beadfected, and incubated for 48 h at 37 °C with 5% CO2. The
coverslips were then washed with PBS (three 2-ml washes; Invitro-
gen, Paisley, UK) and fixed with 1% paraformaldehyde (20 min, 4 °C).
Coverslips were again washed (three washes, each with 2 ml of PBS),
permeabilized with 1% Trition X-100 in PBS for 30 min at room
temperature (permeabilized samples only), and incubated with anti-
GFP monoclonal antibody (Chemicon, Watford, UK) at 1:1000 dilution
in PBS containing 4% w/v BSA with gentle rocking for 2 h at room
temperature. Coverslips were washed as before and incubated with
SCHEME 1. Derivatization of core-shell microspheres 1 with a cell-cleavable linker, subsequent internal labeling, and protein
attachment. Reaction scheme showing the derivatization of core-shell microspheres 1. Reaction conditions: (i) TBTU, N,N-diisopropylethyl-
amine, DMF; (ii) 3-mercaptopropionic acid, DMF; (iii) DY-590-maleimide, DMF; (iv) GFP, EDAC, MES, pH 6.0, NaOH.
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phycoerythrin-conjugated secondary antibody (Sigma, Poole, UK) (1:
500 dilution in PBS containing 4% BSA) for 1 h with gentle rocking.
Coverslips were washed and dried before being mounted in mounting
medium (Vector Laboratories, Peterborough, UK). Slides were imaged
with a Zeiss LSM 510 Meta confocal microscope using a Plan Apo-
chromat 63/1.40 objective mounted on an Axioplan 2 motorized
upright stand, with images collected by LSM software (Zeiss). GFP
fluorescence was detected using a Zeiss bandpass (505–550 nm)
filter after excitation at 488 nm. Phycoerythrin fluorescence was de-
tected using a long-pass 560-nm filter after excitation at 543 nm.
Assessment of Cell Viability by CellTiter-Blue® Assay—HeLa cells
were seeded in quadruplet into 96-well plates (Corning, Birmingham,
UK) at 5  103 cells per well and incubated/beadfected as described.
After incubation at 37 °C/5% CO2 for 50 h, cells were washed (three
100-l washes) with phenol red-free DMEM (Invitrogen) supple-
mented with FBS, 100 IU/ml penicillin, 100 g/ml streptomycin, 1 mM
sodium pyruvate, 1 nonessential amino acid supplement, and 4 mM
L-glutamine. The media was then replaced with fresh phenol red-free
medium containing CellTiter-Blue® reagent (100 l of medium  20
l of reagent) per well. Cells were incubated for a further 3 h at 37
°C/5% CO2, and then the absorbance at 620 nm was measured. After
background subtraction, absorbance values were used to calculate
the percentage viability, expressed as a percentage of untreated
controls (which were set as 100% viable). The viability of cells bead-
fected with microspheres was compared with that of controls by
means of one-way analysis of variance with Dunnett’s multiple com-
parison test, with a q value less than 0.05 considered significant.
Assessment of Cell Membrane Integrity via Propidium Iodide Stain-
ing—Sterile coverslips (12-mm diameter) were placed into 12-well
plates, and 5  104 cells were seeded into each well in 1.5 ml of
DMEM (Invitrogen) supplemented with FBS, 100 IU/ml penicillin, 100
g/ml streptomycin, 1 mM sodium pyruvate, 1 nonessential amino
acid supplement, and 4 mM L-glutamine. After 24 h of incubation, cells
were beadfected with microspheres 5 and 6, and control cells were
left untreated. After a further 48-, 72-, or 96-h incubation, media was
removed from the wells and the coverslips were washed three times
with fresh phenol red-free medium. Propidium iodide at a final con-
centration of 1 g/ml dissolved in phenol red-free medium (1.5 ml)
was then placed into each well, and the plates were returned to the
incubator for 30 min at 37 °C. The medium–propidium iodide solution
was removed, and the coverslips were washed three times with fresh
phenol red-free medium and then placed inverted on microscope
slides. Propidium iodide fluorescence was imaged on a Leica TCS
SP5 II confocal system with a DMI 6000B microscope and an HC Plan
Apochromat 20/0.7 dry objective using excitation at 543 nm with
emission collected between 625 and 780 nm. Three fields of view
were randomly obtained for each sample and imaged at the focal
depth of detectable propidium iodide fluorescence. The numbers of
cells in each image that were stained by propidium iodide and un-
stained were then counted using ImageJ software (28), and these
numbers were used to calculate the percentage of viable cells.
RESULTS
Confirmation of Cellular Uptake—We have recently de-
scribed the synthesis and characterization of 1-m, core-shell,
polystyrene-based microspheres possessing a fluorescently la-
beled, hydrophobic core and a carboxylic-acid-functionalized,
hydrophilic shell with a surface carboxyl loading of60 mol/g
(1). The microspheres have a smooth appearance (under
scanning electron microscopy), are reasonably monodis-
perse, are readily taken up by HeLa cells, and are nontoxic to
those cells (1). Previous, preliminary experiments had shown
that mouse neuronal stem cells also take up these naked
microspheres and do so with 98.8% efficiency, confirming
that the core-shell microspheres behave similarly in terms of
cellular uptake to more conventional polystyrene-based mi-
crospheres (5). However, current evidence that polystyrene-
based microspheres enter cells relies mainly on FACS-based
data (1, 4, 5, 7, 8). Although these data have been confirmed
by various means, including heparin or heparin-sulfate strip-
ping (to remove microspheres adhering to the outside of the
cell membrane) (5), trypan blue quenching of external micro-
spheres (3–5, 8), and live cell imaging of beadfected cells with
DiI-stained membranes (5), some still consider the concept of
microsphere uptake controversial. We therefore sought alter-
native means to confirm both that our microspheres are taken
up by cells and that they can import a biological cargo.
Our published core-shell microspheres (in which the core is
labeled with DY-630 and the shell carries covalently bound
GFP (1; microspheres 10a)) were used as a starting point in
the current study. These microspheres were beadfected into
HeLa cells, which were then imaged as a Z stack. As succes-
sive focal depths were traversed and the center of the cells
was approached, microspheres came into focus. That focus
was lost as the focal plane moved further up the cells, indi-
cating successful beadfection (supplemental Fig. S1). This
evidence was indicative of internalization, but it was not ab-
solute proof, because imaging had been performed on an
epifluorescent microscope. Thus, to confirm internalization,
additional HeLa cells were beadfected with DY-630/GFP de-
rivatized microspheres and then either fixed or fixed and
permeabilized. The cells were then examined via indirect im-
munofluorescence with mouse anti-GFP antibody and a sec-
ondary anti-mouse/phycoerythrin conjugate antibody. In fixed
cells, this should result in extracellular microspheres being
stained red and internalized microspheres remaining un-
stained (the cell membrane forms a barrier to antibody ac-
cess). In contrast, cells that are fixed and permeabilized prior
to immunostaining should permit antibody access to the cy-
toplasm and thus to the internalized microspheres. In such a
case all microspheres, whether internal or external, should
stain red. As shown in Fig. 1, the majority of microspheres in
the fixed cells fluoresced green (GFP) but were not stained red
(anti-GFP) (see Figs. 1ai and 1aii), demonstrating both that the
microspheres had been internalized and, from the GFP signal,
that the internalized GFP remained intact (lack of a GFP signal
would indicate either denaturation or degradation of the GFP
on the microspheres). Microspheres that were clearly outside
these nonpermeabilized cells fluoresced both green and red
(white arrow, Fig. 1aiv with Figs. 1ai–1aiii). The presence of
internalized GFP was confirmed by the dual green and red
staining within permeabilized cells, where the antibody had
access to the intracellular environment (Figs. 1bi–1biv). Thus
these immunostaining data both support the validity of the
epifluorescent data taken at a focal plane within the cells and,
more important, demonstrate unambiguously that our core-
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shell microspheres were able to enter cells and transduce an
intact protein cargo.
Development of Generic Bioconjugation and Delivery
Chemistry—Facile bioconjugation between the carrier (here,
the microsphere) and the protein is required for a generic
protein-delivery protocol. The many techniques available with
which to immobilize protein covalently to support surfaces are
the subject of a recent review (29), but two of the most
common involve either EDC/EDAC or glutaraldehyde/cyano-
borohydride-mediated couplings with any amine available on
the protein surface to immobilize protein via amide or amine
bonds, respectively. As previously demonstrated (1, 5, 7),
such methods enable effective protein delivery via beadfec-
tion, but subsequently the protein remains permanently teth-
ered to the microspheres.
Disulfide linkers have been used effectively in the delivery of
nucleic acids to cells (27, 30) and in releasing protein from
nanocapsules (31). Such linkers permit intracellular release
from a carrier because the cytoplasm of mammalian cells is
maintained as a reducing environment, containing high con-
centrations of reduced glutathione (tripeptide -glutamyl-cys-
teinyl-glycine), which cleaves disulfide bonds to generate free
thiols. Thus, an obvious approach would be to conjugate
protein to microspheres via disulfide-based cleavable linkers
such as N-succinimidyl 3-(2-pyridyldithiopropionate). Al-
though linkers of this type are readily available, their advan-
tage is negated by the requirement that a free thiol be acces-
sible for coupling on the protein’s surface. Consequently, this
often necessitates mutagenesis/engineering of the protein to
introduce the thiol moiety in the form of a free cysteine resi-
due. Nevertheless, we elected to assess this conventional,
disulfide-based methodology. A suitable free thiol near the
amino terminus of GFP was engineered, and the resulting
Cys-GFP protein was coupled to microspheres via an N-
succinimidyl 3-(2-pyridyldithiopropionate) linker. Although the
presence of the N-terminal cysteine did not affect protein
fluorescence, only weakly fluorescent microspheres resulted,
suggesting that protein loading of the microspheres was low.
Moreover, long incubation times (4 to 6 h) at room tempera-
ture were necessary in order for the protein to attach to the
microspheres with this method. Such lengthy incubations are
clearly undesirable in terms of the stability of many purified
proteins.
Accordingly, we designed a linker that contains a cell-
cleavable disulfide linkage but can couple to any primary
amine on the protein, rather than requiring a free cysteine
residue for immobilization. This approach negates the need to
modify the target protein and combines the speed and ge-
neric application of EDC/EDAC methodology (all proteins
have amino groups available for coupling) with the reversibility
engendered by a disulfide-based linker. The linker was syn-
thesized in situ on the shells of the microspheres 1 (Scheme
1). Specifically, a TBTU-mediated procedure was employed to
couple 3-(2-pyridyldithio)propionyl hydrazide 2 to the carbox-
ylic acid groups within the outer shells of these orthogonally
functionalized microspheres. The resultant thiol-reactive pyr-
idyl derivative 3 was then subjected to disulfide exchange to
generate the corresponding 3-mercaptopropionic acid-de-
rived linker 4. The hydrophobic maleimide-modified dye DY-
590 (Dyomics) was then coupled to the thiol groups within the
polystyrene cores of the microspheres to generate fluor-la-
beled beads 5. Finally, GFP was coupled to the cleavable
FIG. 1. Indirect immunofluorescence analysis of beadfected, fixed HeLa cells. HeLa cells were beadfected with DY-630/GFP derivatized
core-shell microspheres. Samples of the cells were either fixed or fixed and permeabilized. They were then examined via indirect immuno-
fluorescence using mouse anti-GFP antibody and an anti-mouse/phycoerythrin secondary antibody conjugate. Confocal images of GFP and/or
phycoreythrin fluorescence illustrate (a) non-permeabilized cells, (b) permeabilized cells, (i) GFP fluorescence, (ii) phycoerythrin fluorescence,
(iii) co-localization of GFP/phycoerythrin fluorescence, and (iv) combined fluorescent/bright field image to show cellular location. The white
arrow indicates non-internalized microspheres. (Note: microspheres shown in this figure were internally labeled with DY-630, which was
selected solely to imbue the microspheres with chemical characteristics similar to those used in subsequent fluorescence microscopy studies.
It was first confirmed that DY-630 was undetectable by the filter set/wavelengths employed within these experiments.)
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linker in aqueous medium using conventional carbodiimide
chemistry to generate GFP-loaded microspheres 6.
Delivery and Release of Protein within Cells—To test the
delivery and release of protein in cells using the cell-cleavable
linker system, core-shell microspheres were labeled with DY-
590 and freshly loaded with GFP 6 (Scheme 1). As a control,
core-shell microspheres 1 were labeled with DY-590 and
subsequently loaded with GFP using conventional EDAC
chemistry to yield a non-cleavable linkage using methodology
described previously (1). Previous studies (7, 32) indicate that
cellular uptake occurs within about 24 h. Given this time
frame, the onset of GFP cleavage from the microspheres
should be apparent within 24 h if the cell-cleavable linker is
capable both of delivering a protein cargo into cells and
subsequently releasing that cargo within the cytoplasm. We
therefore examined samples of beadfected cells after 24 and
36 h using fluorescence microscopy (Fig. 2).
Fig. 2A demonstrates that the majority of microspheres
were internalized within the cells in under 24 h (note the white
arrow, which indicates external microspheres). Moreover, the
difference between the 24-h and 36-h samples is striking with
regard to microspheres bearing the cleavable linker. Exami-
nation of Figs. 2A and 2B shows that at 24 h, the internalized
microspheres were mostly red, suggesting that the GFP pro-
tein cargo had already been released. However, when green
fluorescence is studied in isolation (Fig. 2C, 24 h cleavable), it
is evident that the internalized beads were all faintly green,
suggesting partial protein release. After 36 h, green fluores-
cence from the internalized microspheres disappeared, indi-
cating that all of the protein had been delivered (Fig. 2C, 36 h
cleavable). (Note that it is unlikely that GFP fluorescence
would be detected after release from the microspheres, be-
cause the protein would be diffuse within the cells, and thus
its cytoplasmic concentration would be too low; in optimized,
extracellular experiments, the lowest concentration of free
GFP that we have been able to detect is 0.4 nM (33).) In
contrast, when GFP was attached to the microspheres via the
non-cleavable linker, green fluorescence remained un-
changed after 36 h (Fig. 2C, 36 h non-cleavable), demonstrat-
ing that the protein was neither degraded nor released from
the microspheres.
To compare the uptake efficiency of these newly derivatized
beads with that of those examined previously, we performed
multiple beadfection experiments and analyzed the resultant
fluorescent images. Beads that were in focus within the cen-
tral sections of z-stacked fluorescent images of the cells were
counted (Table I). As also demonstrated in Fig. 2 and previ-
ously (6, 32), these data again confirmed that cellular uptake
occurred within 24 h. Moreover, we were interested to note
not only that uptake of our GFP-derivatized beads was similar
FIG. 2. Epifluorescent microscopy of beadfected HeLa cells conjugated to GFP via cell-cleavable and non-cleavable linkers. Samples
of HeLa cells were beadfected with DY-590-labeled microspheres conjugated to GFP via a cell-cleavable linker (microspheres 6) or via a
non-cleavable linker (1). All images represent a z-slice taken at a focal plane approximating the center of the cells. A, combined fluorescent/
bright field image. B, DY-590 fluorescence (internal bead label) and GFP fluorescence. C, GFP fluorescence only. D, DY-590 fluorescence only.
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regardless of linker chemistry (supplemental Table S1), but
also that the degree of uptake was remarkably similar,
whether calculated by counting fluorescent images or mea-
sured by FACS (1). We therefore conclude that on the order of
65% to 75% of cells will take up our core-shell microspheres
when loaded with GFP protein.
Beadfection Does Not Compromise Cell Viability or Mem-
brane Integrity—Previous work has shown that microspheres
are nontoxic to a variety of host cells, as described in the
introduction. To confirm that these earlier findings also apply to
our core-shell microspheres, we tested the effect of beadfection
in HeLa cells, by means of both CellTiter-Blue® cell viability
assay (Promega, Southampton, UK) and propidium iodide
staining, to examine membrane integrity. HeLa cells were bead-
fected with either microspheres 5 (derivatized with the cell-
cleavable linker) or microspheres 6 (derivatized with the
cell-cleavable linker coupled to GFP) and compared with non-
beadfected controls. To examine viability, cells were cultured
for 50 h after beadfection and then analyzed via the CellTiter-
Blue® assay. No difference in viability was observed between
control cells and those beadfected with either microspheres 5
or microspheres 6 (Fig. 3A). Similarly, propidium iodide exclu-
sion demonstrated that beadfection with microspheres 5 and
6 had no effect on HeLa cell membrane integrity at 48, 72, or
even 96 h after beadfection (Table II).
The Cell-cleavable Linkage Is Stable When Outside of the
Cell—The final requirement of a generic delivery system is
stable extracellular bioconjugation of the protein cargo. We
therefore incubated GFP-loaded microspheres 6 in used cell
culture medium for 90 h at 37 °C. The microspheres were then
examined via fluorescence microscopy. Fig. 4 demonstrates
both that the GFP remained attached to the microspheres and
that the internal labeling of the microspheres remained effec-
tive even after such prolonged incubation. We conclude that
we have generated microspheres that satisfy all of our re-
quirements for generic protein delivery via bioconjugation be-
tween solid particles and soluble protein.
DISCUSSION
The common approach to studying cellular protein activity
in vitro is transfection with nucleic acid, but this can lead to
problems of dosage, transiency, and/or unwanted genetic
manipulation. Moreover, the number of genes that can be
delivered to a single cell is strictly limited. Thus, protein trans-
duction remains an attractive alternative, but again, the num-
ber of proteins that can be delivered is limited, and as de-
scribed above, avoidance of endocytosis is desirable when
the ultimate aim is to study protein function after delivery.
Microsphere-based protein transduction is attractive be-
cause of the facile and high-efficiency mechanism of entry.
Microspheres are taken up with high efficiency by a wide
variety of cells, apparently without any toxic side effects, and
therefore they show great promise for the delivery of intact,
functional protein into cells. The microspheres described
herein fulfill all of our specified criteria for a protein transduc-
tion reagent. They allow for facile covalent linkage of protein
TABLE I
Efficiency of beadfection of HeLa cells with DY-590 labeled micro-
spheres conjugated to GFP via a cell-cleavable linker (microspheres 6)
or a non-cleavable linker (1)
Linker 24 h (%) 36 h (%)
Cell-cleavable 74.3  5.6 68.1  12.9
Non-cleaveable 64.7  4.9 71.2  15.4
Numbers are the percentage of cells that successfully took up
bead(s) ( S.D.) and were calculated from four experiments per-
formed independently, using cells from three different passage num-
bers. These percentages were calculated by counting beads in focus
within the central section of a z-stack of the cells (e.g. the internal
region of the cells). A total of 600 to 1100 cells were counted for each
determination.
FIG. 3. CellTiter-Blue® analysis of cell viability after beadfec-
tion. HeLa cells from five different passage numbers were beadfected
in quadruplet with microspheres 5 (derivatized with the cell-cleavable
linker only) and 6 (loaded with GFP, linked via the cell-cleavable
linker), cultured for 50 h, and compared with non-beadfected controls
by means of CellTiter-Blue® analysis, as described under “Experi-
mental Procedures.” Data represent means of resazurin reduction,
expressed as a percentage of nontreated controls  S.D.
TABLE II
Cell membrane integrity after beadfection with microspheres 5 (cell-
cleavable linker) and microspheres 6 (cell-cleavable linker conjugated
to GFP), as determined via propidium iodide staining
Time (h) Sample Unstained cells (%)
Control 97.7  2.7
48 Microspheres 5 97.1  2.5
Microspheres 6 98.3  1.7
Control 99.3  0.7
72 Microspheres 5 99.7  0.2
Microspheres 6 99.8  0.3
Control 98.1  0.9
96 Microspheres 5 98.1  1.4
Microspheres 6 98.9  0.7
Cells were grown on coverslips, beadfected, incubated for time
periods as indicated, and stained with propidium iodide as described
in “Experimental Procedures.” Numbers represent the mean percent-
age  S.D. of unstained cells calculated from three experiments
performed independently in triplicate, using cells from three different
passage numbers. Totals of 74 to 529 cells (48 h), 305 to 1140 cells
(72 h), and 414 to 1193 cells (96 h) cells were counted for each field
of view.
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(via a generic, aqueous, carbodiimide-based coupling proce-
dure), which we have demonstrated to be nontoxic to the cells
and stable, extracellularly. We have also shown that the de-
livery efficiency of these microspheres is good, with typically
65% to 75% of the cell population being beadfected success-
fully. Protein may be attached to the microspheres via a
disulfide linkage, which enables spontaneous release within
the cytoplasm, mediated by the reducing intracellular environ-
ment. Alternatively, protein may be linked irreversibly to the
microspheres if required. During and after delivery, the loca-
tion of the microspheres can be tracked simply via the inde-
pendent fluorescent signature of their cores.
Future applications of our microspheres can exploit their
versatility. Although not demonstrated herein, because pro-
tein is joined simply via a free amino group, our microspheres
could in theory carry a mixture of proteins (perhaps those
identified via protein–protein interaction analyses) or indeed
protein(s) complexed with irreversible inhibitors. Alternatively,
the orthogonal nature of their core and shell chemistries
means that any molecule bearing a free amine group can be
linked to the outer shell, and the core can be labeled with any
hydrophobic, thiol-reactive dye/fluor. Thus, our microspheres
should also permit facile delivery/release of nonproteinaceous
molecules such as RNAi, as demonstrated recently (27, 34),
but without the need to attach additional hydrophilic linkers to
confer aqueous compatibility. As discussed above, the differ-
ent chemical reactivities of the core and shell of our micro-
spheres also offer potential for multiplexing using multiple
cargo–fluor combinations.
Finally, although polystyrene microspheres have been em-
ployed in in vivo studies (3, 35) and other, nonbiodegradable
silica-based nanoparticles have been used for drug delivery
(36), the microspheres described herein are not biodegrad-
able and thus are not intended for in vivo use. Rather, they
have been developed as a research tool to facilitate in vitro
functional protein analysis to manipulate cell activity/pheno-
type via the introduction of exogenously derived proteins.
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